OpGen Inc - ESG Rating & Company Profile powered by AI
The assessment of OpGen Inc uses information from across the internet as well as from available disclosures by OpGen Inc. The Disclosure rating includes 17 UN SDGs including: 'Zero Hunger', 'Responsible Production & Consumption' and 'Life on Land'. Scroll down to the bottom of the webpage for potential risks for OpGen Inc based on industry, location and marketcap.
OpGen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 5.3, social score of 4.8 and governance score of 6.0.
5.4
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
627 | Ultimovacs ASA | 5.5 | High |
627 | United Therapeutics Corp | 5.5 | High |
645 | OpGen Inc | 5.4 | High |
645 | Candel Therapeutics Inc | 5.4 | High |
645 | Eiger BioPharmaceuticals Inc | 5.4 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does OpGen Inc have an accelerator or VC vehicle to help deliver innovation?
Does OpGen Inc disclose current and historical energy intensity?
Does OpGen Inc report the average age of the workforce?
Does OpGen Inc reference operational or capital allocation in relation to climate change?
Does OpGen Inc disclose its ethnicity pay gap?
Does OpGen Inc disclose cybersecurity risks?
Does OpGen Inc offer flexible work?
Does OpGen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does OpGen Inc disclose the number of employees in R&D functions?
Does OpGen Inc conduct supply chain audits?
Does OpGen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does OpGen Inc conduct 360 degree staff reviews?
Does OpGen Inc disclose the individual responsible for D&I?
Does OpGen Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does OpGen Inc disclose current and / or historical scope 2 emissions?
Does OpGen Inc disclose water use targets?
Does OpGen Inc have careers partnerships with academic institutions?
Did OpGen Inc have a product recall in the last two years?
Does OpGen Inc disclose incidents of discrimination?
Does OpGen Inc allow for Work Councils/Collective Agreements to be formed?
Has OpGen Inc issued a profit warning in the past 24 months?
Does OpGen Inc disclose parental leave metrics?
Does OpGen Inc disclose climate scenario or pathway analysis?
Does OpGen Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does OpGen Inc disclose the pay ratio of women to men?
Does OpGen Inc support suppliers with sustainability related research and development?
Does OpGen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does OpGen Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is OpGen Inc involved in embryonic stem cell research?
Does OpGen Inc disclose GHG and Air Emissions intensity?
Does OpGen Inc disclose its waste policy?
Does OpGen Inc report according to TCFD requirements?
Does OpGen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does OpGen Inc disclose energy use targets?
Does OpGen Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does OpGen Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for OpGen Inc
These potential risks are based on the size, segment and geographies of the company.
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.